Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults
Clinical trial NCT04502693 · COMPLETED
Trial details
- NCT number
- NCT04502693
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-14
- Primary completion
- 2022-09-13
- Enrollment
- 3657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.